The fibroblast growth factor market presents opportunities in regenerative medicine, oncology, and metabolic disorders due to advances in molecular biology and delivery technologies. Key opportunities ...
Recombinant human fibroblast growth factors offer growth prospects in regenerative medicine and cosmetics, driven by efficient production systems. Key opportunities arise from applications in wound ...
FGF2 offers strategic growth opportunities in regenerative medicine and biopharmaceuticals, driven by advances in expression technologies and innovative delivery systems. Collaborative frameworks and ...
Researchers at Texas A&M University have uncovered a key element of joint cartilage regrowth, which brings them one step ...
Interesting Engineering on MSN
Single protein regenerates entire finger joint, fuels limb regrowth hopes
For the first time, scientists at Texas A&M University have identified a crucial protein that can regrow an entire finger ...
Chemical and biotech company WACKER has announced the launch of a new bioengineered growth factor specially developed for use ...
An investigational triple agonist that targets fibroblast growth factor 21, glucagon and GLP-1 receptors cut triglyceride ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...
Scientists said on Monday they had taken a first step towards being able to control stem cells -- master cells that have the ability to become any kind of cell in the body. Doctors hope one day these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback